Hirohata S, Yanagida T, Itoh K, Nakamura H, Yoshino S, Tomita T, Ochi T
Teikyo University School of Medicine, Tokyo, Japan.
Arthritis Rheum. 1996 May;39(5):836-43. doi: 10.1002/art.1780390517.
To examine the capacity of bone marrow progenitor cells to generate CD14+ cells, in order to assess the role of bone marrow in the pathogenesis of rheumatoid arthritis (RA).
CD14- cells purified from bone marrow specimens of 11 patients with active RA and 8 control patients (osteoarthritis or trauma) were cultured in the presence or absence of granulocyte-macrophage colony-stimulating factor (GM-CSF; 100 pg/ml). After incubation for various lengths of time, the cells were analyzed by flow cytometry for expression of CD14 and HLA-DR.
The spontaneous generation of CD14+ cells from bone marrow CD14- progenitor cells was accelerated in RA patients compared with control patients. Moreover, the expression of HLA-DR on the bone marrow-derived CD14+ cells was also accelerated in RA patients compared with controls. GM-CSF significantly enhanced the generation of CD14+ cells, as well as the expression of HLA-DR, on CD14+ cells of control patients, but not those of RA patients. GM-CSF levels in the culture supernatants of bone marrow CD14- cells were not significantly different between RA patients and control patients (undetectable in most cases).
These observations strongly support the hypothesis that the accelerated generation of CD14+ cells from bone marrow progenitor cells and the accelerated maturation of such CD14+ cells into HLA-DR+ cells play an important role in the pathogenesis of RA. Moreover, the data suggest a functional alteration of RA bone marrow CD14- cells in their responsiveness to GM-CSF.
检测骨髓祖细胞生成CD14+细胞的能力,以评估骨髓在类风湿关节炎(RA)发病机制中的作用。
从11例活动期RA患者和8例对照患者(骨关节炎或创伤患者)的骨髓标本中纯化出CD14-细胞,在有或无粒细胞-巨噬细胞集落刺激因子(GM-CSF;100 pg/ml)存在的情况下进行培养。孵育不同时间后,通过流式细胞术分析细胞中CD14和HLA-DR的表达情况。
与对照患者相比,RA患者骨髓CD14-祖细胞自发生成CD14+细胞的过程加快。此外,与对照相比,RA患者骨髓来源的CD14+细胞上HLA-DR的表达也加快。GM-CSF显著增强了对照患者CD14+细胞中CD14+细胞的生成以及HLA-DR的表达,但对RA患者的细胞无此作用。RA患者和对照患者骨髓CD14-细胞培养上清液中的GM-CSF水平无显著差异(大多数情况下检测不到)。
这些观察结果有力地支持了以下假说,即骨髓祖细胞加速生成CD14+细胞以及此类CD14+细胞加速成熟为HLA-DR+细胞在RA发病机制中起重要作用。此外,数据表明RA骨髓CD14-细胞对GM-CSF的反应存在功能改变。